InvestorsHub Logo
Followers 1184
Posts 134793
Boards Moderated 3
Alias Born 08/27/2003

Re: Trendliner post# 127615

Saturday, 12/03/2016 7:15:44 PM

Saturday, December 03, 2016 7:15:44 PM

Post# of 146211
Actually Seymour did address it in the letter:

"We have been working on developing a number of analysis and characterization assays necessary for enabling batch-to-batch consistent production of our materials since moving to the new campus."

Translation in plain English -- still no batch-to-batch consistent production. What Seymour "forgets" to mention is that without consistent production NNVC is dead in the water. No clinicals. Not even TOX.

The prototype results bullshit -- if one is inclined to believe them -- are completely worthless. Great prototype results are apparently easy with nanomedicine -- being able to make consistent batches to move onto the TOX stage is another story.

No wonder they didn't even bother hiring a virologist until recently. Why bother?

The SwingTrade Portfolio was up 36.2% in 2014, 83.5% in 2013, and 546.6% since inception.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110307454

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News